Additive Manufacturing Strategies

Organovo Initiates Contracting For Their 3D Bioprinted Human Liver Cells

ST Medical Devices

Share this Article

One of the more exciting companies within the 3D Printing space is Organovo. The San Diego based company is using 3D printing technology to print live human tissue. It sounds like something out of a science fiction organovo-1novel, but the company has been making tremendous progress over the last couple of years. Organovo’s ultimate goal is to be able to print out entire functioning human organs. Although such an accomplishment is still many years away, they are already turning heads, and garnering interest from major pharmaceutical companies that are looking to use their bioprinted tissue for pre-clinical trials .

Every year billions of dollars are spent performing pre-clinical testing for drug discovery. These tests usually rely on a variety of methods, most of which are not all that accurate. What Organovo has been working diligently on, has been the development of human tissue samples, specifically liver tissue, aimed towards pre-clinical drug testing and discovery. This week the company announced that they have begun initiating contracts for their patented 3D printed human liver tissue samples, with various pharmaceutical and biotech firms.

Organovo’s Chairman and Chief Executive Officer, Keith Murphy, stated “Organovo has received interest in advance of our planned launch from top 15 pharma company customers, small to midsize pharma companies, biotechnology companies, and private venture capital backed pharmaceutical development firms. The compelling data already generated on the organovo-featperformance of the 3D Human Liver Tissue has driven this interest, we believe, and I’m pleased that our team was able in a short time to accomplish all of the hard work that allowed us to begin signing contracts. We’ll be able to deliver results for proprietary compounds and other needs, while completing the work for fuller product and service launch on our original timeline.”

The company expects to expand their offerings to more clients as the year progresses. The human liver tissue that they are able to print, is capable of surviving long term studies, making them ideal for testing the long term affects of a drug on the human liver. This is a major step towards further monetization of their technology, and will likely allow them to push forward with additional bioprinting applications that they have shown interest in. Discuss this article at the Organovo forum thread at 3DPB.com.

organovo-2

3D Printed Human Liver Tissue

Share this Article


Recent News

New Self-Healing Plastic for 3D Printing Epitomizes Plastic Conundrum

3D Printing Drone Swarms, Pt 11: AI-Powered Boats



Categories

3D Design

3D Printed Art

3D Printed Food

3D Printed Guns


You May Also Like

Nuclear Reactor 3D Printing Method Licensed from ORNL

The U.S. Department of Energy’s Oak Ridge National Laboratory (ORNL) has been making significant progress in 3D printing parts for use in one of the most volatile and dangerous environments:...

3D Printing Drone Swarms, Part 7: Ground & Sea Logistics

As we discuss in our ongoing 3D Printing Drone Swarms series, additive manufacturing (AM) will play an increasing role in the production of all manner of semi-sentient robots. This has...

3D Printed Oil Tanker Parts Approved after 6 Months of Evaluation Use

The oil and gas markets, along with maritime, are less exploited sectors for the additive manufacturing (AM) industry. However, progress is being made in this regard, with a group of...

The Calm Before the Swarm: Notre Dame Researcher 3D Prints Swarm of Robot Insects

The spread of blueprints for DIY gun manufacture has been one of the most infamous developments in 3D printing’s recent history. But this is, of course, far from the only...


Shop

View our broad assortment of in house and third party products.